Blood Group Typing Market to Grow with a CAGR of 8.76% through 2029
Growing Incidence of Chronic Diseases and Emerging Applications in
Transplantation Medicine are the major drivers for the Global Blood Group
Typing Market.
According to TechSci Research report, “Blood Group
Typing Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2029”, the Global Blood Group
Typing Market was valued at USD 2.01 billion in 2023 and will see an
impressive growth in the forecast period at a CAGR of 8.76% to 2029. This can be
attributed to the awareness among individuals regarding Blood Group Typing
which has led to a favorable market. Personalized medicine aims to tailor medical
treatments and interventions to individual patient characteristics, including
their genetic makeup and specific healthcare needs. Blood group typing plays a
crucial role in transfusion medicine by ensuring the compatibility of donor
blood with recipient blood, thereby minimizing the risk of adverse reactions,
and optimizing transfusion outcomes for individual patients.
Personalized medicine prioritizes patient safety and
efficacy by optimizing treatment strategies based on individual factors, such
as blood type, immune status, and genetic predispositions. Accurate blood group
typing is essential for identifying compatible blood products and reducing the
risk of transfusion-related complications, ensuring the safety and
effectiveness of transfusion therapies in personalized medicine approaches. Personalized
medicine recognizes the importance of identifying rare blood types and atypical
blood group phenotypes that may require specialized transfusion strategies.
Blood group typing services enable the detection and characterization of rare
blood types, allowing healthcare providers to identify suitable donors and
compatible blood products for patients with unique transfusion requirements.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "Global Blood Group Typing Market”
Blood transfusions carry the risk of
transmitting infectious agents, including bacteria, viruses, parasites, and
prions, from donor to recipient. TTIs can lead to severe health complications,
including viral hepatitis, HIV/AIDS, malaria, and variant Creutzfeldt-Jakob
disease (vCJD), posing significant risks to patient safety. Blood typing
laboratories must implement rigorous screening protocols to detect and
eliminate infectious agents from donated blood units. Screening tests for TTIs
include nucleic acid testing (NAT), serological assays, and immunoassays
designed to detect the presence of specific pathogens, such as HIV, hepatitis B
virus (HBV), hepatitis C virus (HCV), syphilis, and West Nile virus. The
effectiveness of TTI screening tests depends on their sensitivity, specificity,
and reliability in detecting low levels of infectious agents in donor blood.
Achieving high sensitivity ensures the detection of even low-level viremia or
parasitemia, while high specificity minimizes the risk of false-positive
results and unnecessary blood discards.
The Global Blood Group Typing Market is segmented into
Product, Technique, Test Type, End User, regional distribution, and company.
Based on its Technique, Global Blood Group Typing
Market is segmented into PCR-Based and Microarray Techniques, Assay-Based
Techniques, Massively Parallel Sequencing, Others. Massively
Parallel Sequencing (MPS), also known as next-generation sequencing (NGS), is a
cutting-edge technology that has revolutionized various fields, including blood
group typing. MPS allows for the rapid and high-throughput sequencing of DNA
fragments, enabling the identification of genetic variants associated with
blood group antigens with unprecedented accuracy and efficiency. MPS can detect a
wide range of genetic variations, including single nucleotide polymorphisms
(SNPs), insertions, deletions, and gene rearrangements, associated with blood
group antigens across various blood group systems. By analyzing the entire gene
sequence, MPS provides detailed information about the genetic diversity and
complexity of blood group alleles.
Based on region, North America is dominating the
market. The region has a high prevalence of chronic diseases, such as cancer,
cardiovascular disorders, and blood disorders, which necessitate regular blood
typing and transfusion services. This sustained demand for blood typing
contributes to the prominence of North America in the global market. North
American companies often engage in strategic partnerships and collaborations
with healthcare providers, research institutions, and industry stakeholders to
foster innovation, expand market reach, and address emerging challenges in
blood typing and transfusion practices. North America has one of the highest
healthcare expenditures globally, with substantial investments in medical
research, technology adoption, and patient care. The availability of financial
resources enables healthcare providers to invest in state-of-the-art blood
typing technologies and infrastructure, maintaining the region's leadership in
the global blood group typing market.
Major companies operating in Global Blood Group
Typing Market are:
- Thermo Fisher Scientific inc.
- Danaher Corporation
- Illumina, inc.
- Immucor, inc.
- CareDx Inc.
- Mesa Laboratories, Inc.
- Bio-Rad Laboratories, Inc.
- Merck KgaA
- Quotient, Ltd.
- Day Medical SA
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“Blood Group Typing Market continues to evolve
rapidly, driven by various factors such as increasing demand for blood
transfusions, advancements in blood typing technologies, expanding blood
banking infrastructure, and a growing focus on personalized medicine. Despite
facing challenges such as the complexity of blood group systems, the need for
high accuracy and precision, transfusion-transmitted infections (TTIs), and
others, the market is characterized by significant opportunities for growth and
innovation.,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Blood Group Typing Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast,
2019-2029 Segmented By Product (Consumables, Instruments,
Services), By Technique (PCR-Based and Microarray Techniques, Assay-Based
Techniques, Massively Parallel Sequencing, Others), By Test Type (Antibody
Screening, HLA Typing, ABO Blood Tests, Cross-Matching Tests, Antigen Typing), By
End User (Hospitals, Clinical Laboratories, Blood Banks, Other End Users), By
Region, and By Competition”, has evaluated the future growth
potential of Global Blood Group Typing Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Blood Group Typing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com